Curriculim Vitae

Education and Training

Undergraduate

1973-1977

University of Texas

Austin Texas

B.A. Degree

Graduate

1977-1980

Baylor College of Medicine

Houston Texas

M.D. Degree

Postgraduate

1981-1982

Baylor College of Medicine

Houston Texas

Internship

1982-1985

Baylor College of Medicine

Houston Texas

Residency in Obstetrics and Gynecology

1984-1985

Baylor College of Medicine

Houston Texas

Chief Residency Houston, Texas Obstetrics and Gynecology

1986-1988

Baylor College of Medicine

Houston Texas

Fellowship in Reproductive Endocrinology

Appointments and Positions

Non-Academic Positions

1985-1986

Private Practice

Kelsey-Seybold Clinic

Department of Obstetrics and Gynecology

Houston, Texas

Academic Appointments

1985-1988

Clinical Instructor

Department of Obstetrics and Gynecology

Harris County Hospital District

Houston, Texas

1985-1988

Clinical Instructor

Department of Obstetrics and Gynecology

Baylor College of Medicine

Houston, Texas

1988-1994

Assistant Professor

Reproductive Endocrinology

Department of Obstetrics and Gynecology

Baylor College of Medicine

Houston, Texas

1994-Present

Assistant Clinical Professor

Department of Obstetrics and Gynecology

Baylor College of Medicine

Houston, Texas

1990-1994

Director

Diagnostic Follicular Ultrasound

Division of Reproductive Medicine

Department of Obstetrics and Gynecology

Baylor College of Medicine

Houston, Texas

1992-1994

Director

Operative Laparoscopy

Department of Obstetrics and Gynecology

Ben Taub General Hospital

Harris County Hospital District

Houston, Texas

1994-Present

Obstetrical and Gynecological Associates, P.A.

7550 Fannin

Houston, Texas

Certification and Licensure

1980

State of Texas #F8093

1989

Certification in Obstetrics and Gynecology

American Board of Obstetrics and Gynecology

1990

Fellow, American College of Obstetrics and Gynecology

1992

Certification in Reproductive Endocrinology

American Board of Obstetrics and Gynecology

Division of Reproductive Endocrinology

1999

Recertification in Obstetrics and Gynecology

American Board of Obstetrics and Gynecology

1999

Recertification in Obstetrics and Gynecology

American Board of Obstetrics and Gynecology

Division of Reproductive Endocrinology

Membership in Professional and Scientific Societies

Accreditation Council for Gynecologic Endoscopy, Inc.

American Association of Gynecologic Laparoscopists

American Association of Gynecologic Laparoscopists

American Society for Reproductive Medicine

Endocrine Society

European Society of Human Reproduction and Embryology

Harris County Medical Society

Society of Laparoendoscopic Surgeons

Society of Reproductive Endocrinologists

Society of Reproductive Surgeons

Society for the Study of Reproduction

Texas Association of Obstetricians and Gynecologists

Texas Medical Association

Honors

1978

Student Representative to Southern Medical Association Convention - Baylor College of Medicine

1977-1978

Freshman Class President - Baylor College of Medicine

1978-1979

Clinical Class Student President - Baylor College of Medicine

1979-1980

Student Member, Admissions Committee - Baylor College of Medicine

1980

Senior Class President - Baylor College of Medicine

1980

Administrative Chief Resident, Department of Obstetrics and Gynecology - Baylor College of Medicine

1985

Arthur Faris Award for Resident's Day Research Presentation

1985

Senior Resident Teaching Award, Department of Obstetrics and Gynecology, Baylor College of Medicine

1993-1994

Faculty Teaching Award, Department of Obstetrics and Gynecology, Baylor College of Medicine

1994-1995

Voluntary Faculty Teaching Award, Department of Obstetrics and Gynecology, Baylor College of Medicine

Professional Activities

Consulting

1986-1995

Consultant, Genentech, Inc., South San Francisco, California

1990-1992

Consultant, Ethicon, Inc., Somerville, New Jersey

1992-1995

Consultant, Focal, Inc., Boston, Massachusetts

1997-2000

Consultant, IOTEK, Inc., Minneapolis, Minnesota

1997-2002

Consultant, Gliatech, Inc., Cleveland, Ohio

1998-Present

Consultant, Confluent Surgical, Inc., Bedford, Massachusetts

Ancillary Teaching

1986-1989

Instructor, Houston Laser Institute. Sponsored by the Woman's Hospital of Texas, Houston, Texas and the American Fertility Society

Staff Appointments

1988-2004

Active Staff, The Methodist Hospital, Houston, Texas

1988-2003

Active Staff, St. Luke's Episcopal Hospital, Houston, Texas

1988-present

Active Staff, St. Luke's Episcopal Hospital, Houston, Texas

Grants Received

1986

Women's Fund Grant for Academic Research

1986-1989

Unrestricted Grant for Academic Research from Genentech

1991

Women's Fund Grant for Academic Research

1993

Unrestricted Grant for Academic Research from Genentech

1996-1997

Symond's Fund Unrestricted Research Grant

1998-1999

NIH Grant with Dr. Hungnan Loh from Gliatech

Publications

Articles in Peer-Reviewed Journals

1. Dunn R, Lee W, and Cotton DB. Evaluation by computerized axial tomography of eclamptic women with seizures refractory to magnesium sulfate therapy. Am J Obstet Gynecol 155:267-268, 1986.
2. Dunn RC, Gibbons WE and Rossavik IV. Comparison of growth curve analysis of follicular growth between pregnant and nonpregnant patients in an in vitro fertilization program. Infertility 11:245-253, 1988.
3. Dunn RC and Cotton DB. Letter to the Editor. Evaluation of computerized axial tomography of eclamptic women with seizures refractory to magnesium therapy. Am J Obstet Gynecol 158:445, 1988.
4. Doody KJ, Dunn RC, and Buttram Jr. VC. Recombinant tissue plasminogen activator reduces adhesion formation in a rabbit uterine horn model. Fertil Steril 51:509-512, 1989.
5. Uribe MA, Dunn RC, and Buttram Jr. VC. Tubal pregnancy with normal hysterosalpingogram and negative serum pregnancy test. Obstet Gynecol 75:483-486, 1990.
6. Dunn RC, Mohler M. Formation of adhesions after surgical injury and their prevention with tissue-type plasminogen activator in a rabbit pelvic model. Infertility 13:103-111, 1990.
7. Strauss GH, Dunn ET, Dunn RC, Bodiford GB, Christie J. Subconjunctival high dose plasminogen activator in rabbit filtration surgery. J Ocular Pharm 7:1, 1991.
8. Dunn RC, Steinleitner AJ, and Lambert H. Synergistic effect of intraperitoneally administered calcium channel blockade and recombinant tissue plasminogen activator to prevent adhesion formation in an animal model. Am J Obstet Gynecol 164:1327-1330, 1991.
9. Dunn RC, Mohler M. Effect of varying days of tissue plasminogen activator therapy on the prevention of postsurgical adhesions in a rabbit model. J Surg Res 54:242-245, 1993.
10. Hill-West JL, Chowdhury SM, Sawhney AS, Pathak CP, Dunn RC, and Hubbell JA. Prevention of postoperative adhesions in the rat by in situ photopolymerization of bioresorbable hydrogel barriers. Obstet Gynecol 83:59-64, 1994.
11. Whitworth CM, Mulholland J, Dunn RC, Glasser S. Growth factor effects on endometrial epithelial cell differentiation and protein synthesis in vitro. Fertil & Steril 61(1):91-96, 1994.
12. Hill-West JL, Chowdhury SM, Dunn RC, Hubbell JA. Efficacy of a resorbable hydrogel barrier, oxidized regenerated cellulose, and hyaluronic acid in the prevention of ovarian adhesions in a rabbit model. Fertil & Steril 62(3):630-634, 1994.
13. Wun W, Cisneros P, Dunn R, Grunert G. Vitamin supplements improve the fertility potential of a subfertile male with macrocytic anemia - A Case Study. JARG, 11(7):375-378, 1994.
14. Sawhney AS, Pathak CP, Van Rensburg J, Dunn RC, Hubbell JA. Optimization of photopolymerized bioerodible hydrogel properties for adhesion prevention. J Biomedical Materials Research 28:831-838, 1994.
15. 15. Wright S, Valdes CT, Dunn RC, Franklin RR: Short term Lupron or danazol therapy for pelvic endometriosis. Fertil & Steril, 63(3):504-507, 1995.
16. Belfort MA, Saade GR, Snabes M, Dunn RC, Moise KJ, Cruz A, Young R. Hormonal status affects the reactivity of the female cerebral vasculature. Am J Obstet Gynecol, 172:1273-1278, 1995.
17. Hill-West JL, Dunn RC, Hubbell, JA: Local release of fibrinolytic agents for adhesion prevention. J Surg Res 59:759-763, 1995.
18. Dunn RC, Taskin O: Features of a chronic ectopic pregnancy after clinically successful methotrexate treatment of a persistent ectopic pregnancy. Intl J Obstet Gynecol, 51:247-249, 1995.
19. Hill-West JL, Chowdhury SM, Sawhney AS, Pathak CP, Dunn RC and Hubbell JA. Efficacy of a resorbable hydrogel, oxidized regenerated cellulose, and hyaluronic acid adhesions barriers. J Repro Med 41(3):149-154, 1996.
20. Taskin O, Mangal R, Dunn RC, Franklin R, Buttram VC, Poindexter AN, Wiehle RD. Insulin-like growth factor binding proteins in peritoneal fluid of women with mild endometriosis. Human Reprod, 11(8): 1741-1746, 1996.
21. Shaffer LG, Spikes AS, Macha M., Dunn RC: Identification of a subtle chromosomal translocation in a family with recurrent miscarriages and a child with multiple congenital anomalies. J Reprod Med, 40:367-71;1996.
22. Wun WS, Wun CC, Valdes CT, Dunn RC, Grunert GM: Optimal semination concentration for human in vitro fertilization (IVF). Chinese Journal of Physiology, 40(4):227-236, 1997.
23. Wun WS, Wun CC, Valdes CT, Dunn RC, Grunert GM: Blastocyst formation is a good indicator for attainment of assisted reproduction. Chinese Journal of Physiology, 40(4): 237-242, 1997.
24. Gullet J, Grunert GM, Valdes CT, Dunn RC, Wun WSA: Low blastocyst formation rates in day-2 fertilized oocytes. JARG, 15(10): 594-598, 1998.
25. Wun WSA, Gullet J, Dunn RC, Valdes CT, Grunert GM: The development of one pronucleus "zygotes" is abnormal. Assisted Reproduction Reviews, 9(2); 65-69, April 1999.
26. Bacevice A, Bieber EJ, Dunn RC, et al.: Assessment of Pelvic Adhesions: Statistical Validation, Reliability and Inter-Observer Correlation Using a Modification of the More Comprehensive Adhesion Scoring Method (MCASM). Fertil Steril, 74(3)(Suppl 1); S85, September 2000.
27. Dunn R, Lyman BS, Edelman PG, Campbell PK: Evaluation of the SprayGelT Adhesion Barrier in the Rat Cecum Abrasion and Rabbit Uterine Horn Adhesion Models. Fertil Steril, 75(2); 411-416, February 2001.
28. Chang P, Kenley S, Burns T, Denton G, Currie K, DeVane G, O'Dea L, et al.: Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel R) to urinary hCG (Profasi R) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril, 76(1); 67-74, July 2001.
29. Diamond MP, Luciano A, Johns DA, Dunn RC, Young P, Bieber, E: Reduction of postoperative adhesions by N,O-carboxymethylchitosan: a pilot study. Fertil Steril, 80(3); 631-636, September 2003.
30. Johns DA, Ferland R, Dunn RC, et al.: Initial Feasibility Study of a Sprayable Hydrogel Adhesion Barrier System in Patients Undergoing Laparoscopic Ovarian Surgery. AAGL submitted.
31. Grunert GM, Wun AWS, Cheung SW, Dunn RC, et al: Blastocyst formation is not an indication of genetically normal embryos. Fertil Steril 80(3)(Suppl 3); S201, September 2003.
32. Dunn R, Hantes J: Double cervix and vagina with a normal uterus and blind cervical pouch: A rare müllerian anomaly. Fertil Steril 82(2); 458-459, August 2004.

Chapters in Books

1. Dunn RC and Buttram VC JR: Tissue-type plasminogen activator as an adjuvant for post-surgical adhesions. In: Progress in Clinical and Biological Research 358: Treatment of Post-Surgical Adhesions. John Wiley & Sons, Inc., New York, 1990.
2. Dunn RC: Adhesions/adhesiolysis and plasminogen activators. In: Assisted Reproductive Technology/Andrology. Hemisphere Publishing Corp., Washington, D.C., 1990. pp. 130-137.
3. Dunn RC: Tissue-type plasminogen activator and adhesion prevention. In: Progress in Clinical and Biological Research 381: Gynecologic Surgery and Adhesion Prevention. John Wiley & Sons, Inc., New York, 1993. pp. 213-220.
4. Dunn RC: Hysteroscopy. In: Advances in Obstetrics and Gynecology, Volume 1. Mosby -YearBook, Inc., Chicago, IL., 1994, pp. 3-12.
5. Dunn RC: Tissue plasminogen activator. In: Infertility and Reproductive Medicine Clinics of North America. W.B. Saunders Company, Philadelphia, PA., 1994, 5(3):529-538.

Abstracts

1. Dunn RC, Doody KJ, Buttram VC, Jr. and Nguyen T: Use of tissue plasminogen activator to reduce postoperative adhesions in the rabbit uterine horn model. Annual Meeting of the American Fertility Society, September 28 - October 2, 1987.
2. Weitzman GA, Dunn RC, and Gibbons WE: Comparison of pure FSH (metrodin) and human menopausal gonadotropin (pergonal) in combination with clomiphene citrate (CC) for ovarian stimulation in vitro fertilization (IVF). Annual Meeting of the American Fertility Society, September 28 - October 2, 1987.
3. Dunn RC, Gibbons WE and Rossavik IK: Growth curve analysis of follicular growth in an in vitro fertilization program. Annual Meeting of the American Fertility Society, October 8-13, 1988.
4. Dunn RC, Doody K and Mohler M: Development of a reproducible pelvic model for postsurgical adhesion formation in a primate species. Annual Meeting of the American Fertility Society, October 8-13, 1988.
5. Dunn RC and Mohler M: Prevention of recurrent adhesion formation by varying total days of therapy of recombinant tissue-type plasminogen activator in a rabbit uterine horn model. XIII World Congress on Fertility and Sterility, Marrakesh, Morocco, October 1-6, 1989.
6. Mohler M and Dunn RC: Use of a topical recombinant tissue-type plasminogen activator to reduce adhesions in a rabbit uterine horn adhesion model. XIII World Congress on Fertility and Sterility, Marrakesh, Morocco, October 1-6, 1989.
7. Dunn RC, Steinleitner AJ, and Lambert H: Synergistic effect of calcium channel blockade and recombinant tissue plasminogen activator to prevent adhesions via a continuous intraperitoneal pump. Annual Meeting of the American Fertility Society, November 13-16, 1989.
8. Dunn RC and Mohler M: Treatment duration effect of recombinant tissue-type plasminogen activator to prevent adhesion formation in rabbit uterine horn model. Annual Meeting of the American Fertility Society, November 13-16, 1989.
9. Valdes CT, Dunn RC, and Franklin RR: Short term Lupron or danazol therapy for pelvic endometriosis. Annual Meeting of the American Fertility Society, November 13-16, 1989.
10. Dunn RC: A longitudinal, observational study of adhesion reformation and de novo adhesion formation after laparoscopic adhesiolysis. Annual Meeting of the American Fertility Society, October 19-24, 1991.
11. Whitworth CM, Dunn RC, Glasser SR: Growth factor effects on endometrial epithelial cell differentiation and protein synthesis in vitro. Annual Meeting of the American Fertility Society, October 19-24, 1991.
12. Sawhney AS, Pathak CP, Hubbell JA, Dunn RC: Prevention of postoperative adhesions using photopolymerizable biodegradable hydrogels. Annual Meeting of the Society for Gynecologic Investigation, March 18-21, 1992.
13. Pathak CP, Sawhney AS, Dunn RC, Hubbell JA: Photopolymerizable biodegradable hydrogels for the prevention of postoperative adhesions. Fourth World Congress on Biomaterials, Berlin, April 1992.
14. Anania C, Dunn RC: Adhesion reformation and de novo formation after laparoscopic adhesiolysis: A Prospective Report. American College of Obstetrics and Gynecologist District VII Annual Meeting, September 28-30, 1992.
15. Sawhney AS, Pathak CP, Hubbell JA, Dunn RC: Prevention of postoperative adhesions in a rabbit uterine horn model using a photopolymerizable biodegradable precursor. Annual Meeting of the American Fertility Society, November 2-5, 1992.
16. Spikes A, Macha ME, Dunn RC, Shaffer LG: Identification of a subtle translocation and the use of chromosome painting probes in a family with recurrent miscarriages and a child with MCA. Annual Meeting of the American Cytogenetics Conference, March 22-26, 1993.
17. Hill JL, Sawhney AS, Pathak CP, Chowdhury MD, Dunn RC, Hubbell JA: In situ photopolymerization of biodegradable hydrogels for prevention of post-operative adhesions. Annual Meeting of the American College of Obstetrics and Gynecologists, May 3-6, 1993.
18. Hill-West JL, Sawhney AS, Pathak CP, Dunn RC, Hubbell JA: Biodegradable hydrogels for prevention of post-operative adhesions. Annual Meeting of the American Fertility Society, October 9-14, 1993.
19. Taskin O, Mangal R, Dunn RC, Aruh I, Franklin R, Buttram VC, Poindexter AN, Wiehle RD: Insulin-like growth factor binding proteins in peritoneal fluid of women with mild endometriosis. Annual Meeting of the American Fertility Society, October 9-14, 1993.
20. Rosenberg S, Yuzpe AA, Alken M, Dunn RC, Gantt P, Gianfortoni JG, Maxson WS, Webster B: A randomized comparative multicenter trial of ovulation induction (OI) using FSH/hCG vs. intrauterine insemination (IUI) vs. combined OI and IUI for couples with male factor infertility. Annual Meeting of the American Fertility Society, October 9-14, 1993.
21. Hubbell JA, Hill-West J, Dunn RC: In situ photopolymerization of hydrogels for the prevention of postoperative adhesions. 2nd US-Japan Conference on Controlled Drug Delivery, Maui, December 1993.
22. Hill-West JL, Chowdhury SM, Hubbell JA, Dunn RC: Local release of fibrinolytic agents for the prevention of postoperative adhesions. Annual Meeting of the Society for Gynecologic Investigation, March 23-25, 1994.
23. Hill-West JL, Dunn RC, Hubbell JA: Comparison of photopolymerized hydrogel and poloxamer 407 as barriers for adhesions prevention. Fiftieth Annual Meeting of the American Fertility Society, November 1994.
24. Aruh I, Sonmez AS, Hsi BP, Dunn RC, Choung CJ: Relationship between growth hormone (GH) secretion, insulin-like growth factor I (IGF-1) levels and obesity. Fiftieth Annual Meeting of the American Fertility Society, November 1994.
25. Visoski AY, Lipshultz LI, Wun A, Grunert G, Valdes C, Dunn RC, Carson SA, Cisneros P, Lamb DJ: Intracytoplasmic insertion of sperm (ICSI) for severe male factor infertility. Annual Meeting of the American Urological Association, April 1995.
26. Aruh I, Sonmez AS, Dunn RC, Kaufman RH, Chuong CJ. Non-surgical female sterilization using a two-component fibrin sealant: a preliminary study in rabbits. Annual Meeting of the American College of Obstetrics and Gynecology, San Francisco, May 1995.
27. Belfort MA, Saade GR, Snabes M, Dunn RC, Cruz AL, Lang AW, Young RL, Rokey R: The acute effect of 17ß estradiol on cardiac function and cerebral blood velocities. 43rd Annual Meeting of the Society of Gynecologic Investigation, March 20-23, 1996.
28. Hoekstra T, Witt M, Jaffe T, Carson S, Grunert G, Buster J, Casson P, Dunn RC, Valdes C, Lamb D, Wun WS, Gvakhari M, Tucker M, Kattan M, Lipshultz L: Effect of sperm source on embryo grade and rate of cell division after intracytoplasmic sperm injection. Annual Meeting of the American Urological Association, New Orleans, LA, 1997.
29. Tripp BM, Gvakharia M, Carson SA, Buster JE, Casson P, Cisneros P, Grunert GM, Dunn R, Valdes CT, Lipshultz LI, Lamb DJ: The treatment of infertile patients with an abnormal sperm penetration assay (SPA) by intracytoplasmic sperm injection. Annual Meeting of the American Urological Association, New Orleans, LA, 1997.
30. Aruh I, Kafkasli A, Haus E, Dunn RC, Teasdale T, Chuong CJ: Melatonin (ME), epidermal growth factor (EGF) levels in in-vitro fertilization (IVF) patients. 10th World Congress on In Vitro Fertilization, Vancouver, BC, Canada, 1997.
31. Dunn RC, Wun W-S, Valdes C, Grunert G: The sperm from electroejaculation (EEJ) and MESA gives equal pregnancy outcomes compared to masturbation for ICSI in ART trials. 10th World Congress on In Vitro Fertilization, Vancouver, BC, Canada, 1997.
32. Dunn RC, Wun WS, Valdes CT, Grunert GM: Low pregnancy rates by day 2 ICSI reinsemination is due to the low quality of reinseminated preembryos. 10th World Congress on In Vitro Fertilization, Vancouver, BC, Canada, 1997.
33. Wun WS, Angus, S, Valdes C, Dunn RC, Lamb D, Lipshultz L, Grunert G: Blastulation occurrence is better by the conventional insemination than the ICSI procedure. 10th World Congress on In Vitro Fertilization, Vancouver, BC, Canada, 1997.
34. Wun WS, Wunn CC, Valdes C, Dunn RC, Grunert G: The percentage of blastulation (PB) correlates with patient age and pregnancy outcome. 10th World Congress on In Vitro Fertilization, Vancouver, BC, Canada, 1997.
35. Aruh I, Dunn RC: Melatonin (ME) and B-Endorphine (B-EP) levels in In Vitro Fertilization (IVF) patients. 53rd Annual Meeting of the American Society for Reproductive Medicine, Cincinnati, OH, October 1997.
36. Wun WS, Dunn RC, Valdes CT, Grunert GM: Mathematical model to detect the rate limiting step of A.R.T. Pacific Coast Fertility Society Annual Meeting, Indian Wells, CA, April 1998.
37. Angus SC, Valdes CT, Dunn RC, Wun CC, Grunert GM, Wun WSA: Low blastulation rate by ICSI is not due to the injection of Polyvinyl-pyrrolidone (PVP) or the interference of the mixture of the injected spermatozoon with the ooplasm. American Society for Reproductive Medicine Annual Meeting, San Francisco, California, October 3-9, 1998.
38. Wun WSA, Angus SC, Wun CC, Chen BC, Dunn RC, Valdes CT, Grunert GM: Augmentation of embryo development by combination of optimal medium. American Society for Reproductive Medicine Annual Meeting, San Francisco, California, October 3-9, 1998.
39. Wun WSA, Valdes CT, Dunn RC, Wun CC, Grunert GM: Low blastocyst formation rate by ICSI is not due to the subnormal sperm quality. American Society for Reproductive Medicine Annual Meeting, San Francisco, California, October 3-9, 1998.
40. Grunert GM, Dunn RC, Valdes CT, Wun CC, Wun WSA: Comparison of Wallace, Frydman DT, and Cook embryo transfer catheter for IVF: A prospective randomized study. American Society for Reproductive Medicine Annual Meeting, San Francisco, California, October 3-9, 1998.
41. Strandell A, Thorburn J, Tronstad SE, Hompes P, Boer-Meisel M, Bemelman W, Peters A, Leach R, Diamond M, Valdes C, Dunn RC: Effectiveness and safety of a bioabsorbable carbohydrate solution for prevention of post-operative adhesions in pelvic surgery. American Society for Reproductive Medicine Annual Meeting, San Francisco, California, October 3-9, 1998.
42. Dunn RC, Valdes CT, Grunert GM, Wun CC, Wun WSA: Zona dissolution (ZD) enhances pregnancy for ICSI patients. ESHRE Meeting, Tours, France, June 27-30, 1999.
43. Dunn RC, Valdes CT, Grunert GM, Wun CC, Wun WSA: ICSI gives lower pregnancy and implantation rates than IVG. ESHRE Meeting, Tours, France, June 27-30, 1999.
44. Dunn RC, Valdes CT, Bemelman WA, Peters AAW, Strandell AM, Thorburn JO, et al: Effectiveness and safety of a bioabsorbable adhesion control barrier solution for prevention of post-operative adhesions in a pilot clinical study. ESHRE Meeting, Tours, France, June 27-30, 1999.
45. Bemelman WA, Peters A, Strandell A, Thornburn J, Tronstad S, Hompes P, Boer-Meisel M, Leach R, Diamond M, Valdes C, Dunn RC: Effectiveness and safety of a bioabsorbable adhesion barrier solution for the prevention of postoperative adhesions in a pilot clinical study. European Association for Endoscopic Surgery Annual Meeting, Linz, Austria, June 23-26, 1999.
46. U.S. Gonal F Multicenter Clinical Trial Group: A phase III, open-label, multicenter study to evaluate the safety and efficacy of recombinant human follicle stimulating hormone (Gonal-F) administered by the subcutaneous route during pituitary desensitization, for multiple follicle development in 100 women undergoing In-Vitro Fertilization and Embryo Transfer. ESHRE Meeting, Tours, France, June 27-30, 1999.
47. Assessment of Interobserver Consistency in Pregnancy Outcome Counseling. ASRM Annual meeting, San Diego, California, October 21-25, 2000.
48. Assessment of Pelvic Adhesions: Statistical Validation, Reliability and Interobserver Correlation Using a Modification of the More Comprehensive Adhesions Scoring Method (MCASM). ASRM Annual meeting, San Diego, California, October 21-25, 2000. The Society of Reproductive Surgeons Prize Paper.
49. Dunn RC, Lyman MD, Mulani D, Sawhney AS: Evaluation of a sprayable postsurgical adhesion barrier in two rodent models. AAGL Annual Meeting, Orlando, Florida, November 15-19, 2000.
50. Dunn RC, Johns D and Ferland R: Pilot, Blinded, Evaluation of Adhesion Barrier System. ESHRE P-577-Vienna, July 2002.
51. Wan-Song A. Wun, G. Grunert, RC Dunn et al.: The quality of inner cell mass (ICM) correlates with clinical spontaneous abortion (SAB). ASRM Annual Meeting, October 12-17, 2002.
52. Armstrong VC, Johns DA, Ferland R, Dunn RC: Initial Feasibility Study of Sprayable Hydrogel Adhesion Barrier System in Patients Undergoing Laparoscopic Ovarian Surgery. AAGL 31st Annual Meeting, November 20-24, 2002
53. Sahin L, Wun A, Dunn RC, Savan K, Sonmez S: Blastocyst Formation is not a sensitive indicator for chromosone constitution. Fifth International Symposium on Preimplantation Genetics, June 5-7, 2003.
54. Grunert GM, Wun WSA, Cheung SW, Dunn RC, Valdes CT, Schenk L. Blastocyst formation is not an indication of genetically normal embryos. American Society for Reproductive Medicine Seattle, WA, October 2003.
55. Grunert GM, Dunn RC, Valdes CT, Schenk L, Mangal RK, Wun WA. Prostacyclin agonist (Iloprost) enhances human embryo development. American Society for Reproductive Medicine/Canadian Fertility and Andrology Society, Montreal, Quebec, Canada, October 2005.
56. Angus S, Grunert GM, Dunn RC, Valdes CT, Schenk LM, Mangal RK. No advantage of using the sequential GIII media versus the single media global. American Society for Reproductive Medicine, New Orleans, LA, October 2006.
57. Wun WA, Cooper ML, Grunert GM, Dunn RC, Valdes CT, Schenk L. The number of pronuclei does not reflect the number of ploidy. American Society for Reproductive Medicine, New Orleans, LA, October 2006.

Patents

1. Local delivery of fibrinolysis enhancing agents. Hubbell JA, Hill-West JL, Dunn RC. Issued 12/10/93 #08/165,392.